News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
738,707 Results
Type
Article (42474)
Company Profile (191)
Press Release (696031)
Multimedia
Podcasts (97)
Webinars (22)
Section
Business (234989)
Career Advice (2039)
Deals (35711)
Drug Delivery (136)
Drug Development (81876)
Employer Resources (173)
FDA (16673)
Job Trends (15050)
News (348108)
Policy (32887)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2636)
Accelerated approval (56)
ADA (44)
Adcomms (30)
Allergies (194)
Alliances (49765)
ALS (227)
Alzheimer's disease (1877)
Antibody-drug conjugate (ADC) (529)
Approvals (17161)
Artificial intelligence (744)
ASCO (327)
Autoimmune disease (350)
Automation (63)
Bankruptcy (365)
Best Places to Work (11671)
BIO (70)
BIOSECURE Act (20)
Biosimilars (239)
Biotechnology (124)
Bladder cancer (205)
Brain cancer (76)
Breast cancer (812)
Cancer (6380)
Cardiovascular disease (517)
Career advice (1736)
Career pathing (45)
CAR-T (358)
CDC (58)
Celiac Disease (3)
Cell therapy (973)
Cervical cancer (56)
Clinical research (71834)
Collaboration (2238)
Commercialization (1)
Company closure (5)
Compensation (1531)
Complete response letters (90)
COVID-19 (2770)
CRISPR (119)
C-suite (1269)
Cystic fibrosis (158)
Data (8758)
Decentralized trials (3)
Denatured (29)
Depression (179)
Dermatology (101)
Diabetes (674)
Diagnostics (7096)
Digital health (65)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (366)
Drug pricing (204)
Drug shortages (31)
Duchenne muscular dystrophy (308)
Earnings (92384)
Editorial (69)
Employer branding (21)
Employer resources (155)
Events (121138)
Executive appointments (1139)
FDA (20772)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1881)
Gene editing (249)
Generative AI (64)
Gene therapy (755)
GLP-1 (1104)
Government (4777)
Grass and pollen (6)
Guidances (424)
Healthcare (19303)
Hematology (192)
HIV (91)
Huntington's disease (63)
IgA nephropathy (114)
Immunology and inflammation (304)
Immuno-oncology (106)
Indications (222)
Infectious disease (3139)
Inflammatory bowel disease (223)
Inflation Reduction Act (14)
Influenza (145)
Intellectual property (322)
Interviews (321)
IPO (16702)
IRA (50)
Job creations (3661)
Job search strategy (1435)
JPM (58)
Kidney cancer (21)
Labor market (112)
Layoffs (578)
Leadership (42)
Legal (7974)
Liver cancer (103)
Longevity (35)
Lung cancer (841)
Lymphoma (481)
Machine learning (65)
Management (61)
Manufacturing (1173)
Marketing (5)
MASH (215)
Medical affairs (1)
Medical device (14178)
Medtech (14358)
Mergers & acquisitions (20339)
Metabolic disorders (1675)
mRNA (234)
Multiple sclerosis (203)
NASH (17)
Neurodegenerative disease (472)
Neuropsychiatric disorders (109)
Neuroscience (3540)
Neurotech (1)
NextGen: Class of 2026 (6565)
Non-profit (4577)
Now hiring (83)
Obesity (768)
Opinion (298)
Ovarian cancer (242)
Pain (270)
Pancreatic cancer (357)
Parkinson's disease (399)
Partnered (36)
Patents (650)
Patient recruitment (790)
Peanut (67)
People (60133)
Pharmaceutical (46)
Pharmacy benefit managers (33)
Phase 1 (22391)
Phase 2 (31652)
Phase 3 (23546)
Pipeline (10058)
Policy (334)
Postmarket research (2581)
Preclinical (9500)
Press Release (64)
Prostate cancer (340)
Psychedelics (59)
Radiopharmaceuticals (349)
Rare diseases (1205)
Real estate (5988)
Recruiting (71)
Regulatory (26019)
Reports (56)
Research institute (2452)
Resumes & cover letters (354)
Rett syndrome (46)
RNA editing (25)
RSV (90)
Schizophrenia (186)
Series A (319)
Series B (234)
Service/supplier (7)
Sickle cell disease (122)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (48)
Startups (3681)
State (2)
Stomach cancer (18)
Supply chain (134)
Tariffs (87)
The Weekly (66)
Vaccines (1162)
Venture capital (124)
Weight loss (488)
Women's health (138)
Worklife (21)
Date
Today (81)
Last 7 days (408)
Last 30 days (2072)
Last 365 days (30572)
2026 (16821)
2025 (30273)
2024 (35257)
2023 (40237)
2022 (51342)
2021 (55852)
2020 (54275)
2019 (46787)
2018 (35216)
2017 (32245)
2016 (31666)
2015 (37794)
2014 (31483)
2013 (26512)
2012 (28757)
2011 (29438)
2010 (27612)
Location
Africa (747)
Alabama (94)
Alaska (7)
Arizona (371)
Arkansas (14)
Asia (40262)
Australia (6614)
California (14124)
Canada (4010)
China (1516)
Colorado (602)
Connecticut (616)
Delaware (436)
Europe (87380)
Florida (2145)
Georgia (453)
Hawaii (3)
Idaho (63)
Illinois (1165)
India (101)
Indiana (636)
Iowa (24)
Japan (602)
Kansas (134)
Kentucky (53)
Louisiana (59)
Maine (76)
Maryland (1672)
Massachusetts (10132)
Michigan (378)
Minnesota (768)
Mississippi (6)
Missouri (162)
Montana (33)
Nebraska (30)
Nevada (151)
New Hampshire (86)
New Jersey (3689)
New Mexico (31)
New York (3718)
North Carolina (1778)
North Dakota (9)
Northern California (7144)
Ohio (420)
Oklahoma (23)
Oregon (41)
Pennsylvania (2803)
Puerto Rico (31)
Rhode Island (52)
South America (1115)
South Carolina (89)
South Dakota (2)
Southern California (5613)
Tennessee (232)
Texas (2270)
United States (49852)
Utah (423)
Vermont (2)
Virginia (344)
Washington D.C. (81)
Washington State (1132)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
738,707 Results for "mri interventions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
April 1, 2026
·
7 min read
Press Releases
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026
May 7, 2026
·
8 min read
Press Releases
DeepoMe Introduces the First Biomedical World Model for Chronic Disease Management and Aging Intervention
New preprint by Jianghui Xiong, PhD, and the DeepoMe team introduces SteeraMed, a steerable biomedical world model for N-of-1 intervention reasoning across chronic diseases and aging
May 26, 2026
·
1 min read
Press Releases
Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy
May 11, 2026
·
9 min read
Press Releases
Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference
April 29, 2026
·
8 min read
Press Releases
INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer’s Trial
June 2, 2026
·
10 min read
Press Releases
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility
May 14, 2026
·
6 min read
Press Releases
Advancing Diagnostic Care: Saskatchewan’s First Modular MRI Cassette™ to House One of Canada’s First MAGNETOM Flow.Elite MRI Systems
March 11, 2026
·
5 min read
Press Releases
Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions
June 15, 2026
·
10 min read
Press Releases
Esaote advances intraoperative MRI innovation, bringing I-Genius closer to the U.S. market
May 4, 2026
·
3 min read
1 of 73,871
Next
